Creasallis

Iscaff Pharma

This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

CATALYA

This company develops synthetic polymer platform technology to improve the solubility, stability and delivery of biopharmaceuticals for the pharmaceutical and biotechnology industries.

araris

This company develops antibody-drug conjugate linker technology to create targeted cancer therapies for the pharmaceutical and biotechnology industries.

Crescendo Biologics

This company develops antibody fragment therapeutics for oncology and immunology patients and provides drug discovery collaborations to global biopharmaceutical partners.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.